Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimeticsBing Z. Carter, Michael Andreeff, Po Yee Mak et al.|Blood Cancer Journal|2023Cited by 33